This Edition
ARTICLE | Clinical News
Alagebrium: Phase II started
WIR Staff
November 19, 2007 8:00 AM UTC
SYI began the double-blind, placebo-controlled, Dutch Phase II BENEFICIAL trial in 100 patients. ...